Business
RepliCel Appoints Corporate Executive, Hugh Rogers to its Board of Directors
RepliCel Appoints Corporate Executive, Hugh Rogers to its Board of Directors.
About this update from Replicel Life Sciences Inc.
[{"type":"text","content":"\n\n\n\nRepliCel Appoints Corporate Executive, Hugh Rogers to its Board of Directors\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nRepliCel Appoints Corporate Executive, Hugh Rogers to its Board of Directors\nCanada NewsWire\nVANCOUVER, Feb. 3, 2017\n\n\n\nVANCOUVER, Feb. 3, 2017 /CNW/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (\"RepliCel\" or the \"Company\") is pleased to announce the appointment of Hugh Rogers, to its Board of Directors. Mr. Rogers holds a B.Sc. degree from the University of British Columbia and a Legum Baccalaureus (LLB) degree from University of New Brunswick. He is a member in good standing of the law society of British Columbia.\n\nMr. Rogers has extensive corporate finance and restructuring experience through his work with various TSX-V listed issuers and private companies including his most recent roles as Chief Executive Officer of Coronado Resources Ltd. since March 2015 and Vice President Corporate Finance at 3D Signatures Inc. since April 2015. His corporate finance, restructuring and regulatory experience has been primarily focused on start-ups and small cap companies in the resource and biotechnology industries. Mr. Rogers also serves as a Director of Kootenay Zinc Corp. and Coronado Resources Ltd.\n\nRepliCel's Chairman and former CEO, David M. Hall commented, \"We are fortunate to have someone of Hugh's caliber, work ethic and track record of success, join the team. His biotechnology and financing knowledge combined with his network will undoubtedly help us steer the Company forward in achieving its corporate and fiscal goals.\"\n\n\"It's an exciting time to join RepliCel,\" stated Mr. Rogers. \"With data on multiple trials expected early this year and a recently streamlined capital structure, RepliCel has started off 2017 in a very attractive position. I look forward to working with the Company and building value for shareholders.\"\n\n\"Hugh's addition to the Board is another step forward in the Company's transformation that we began in 2016,\" stated RepliCel's President and Chief Executive Officer, R. Lee Bu...